SEMINAR

SAFETY OF ALLERGEN IMMUNOTHERAPY P. 14-28

E.A. Grishchenko

 

Scientific and clinical advisory center of an allergology and immunology, Moscow, Russia

 

This article examines the rate of associated with allergen immunotherapy (AIT) adverse reactions (including severe systemic reactions), risk factors for systemic reactions, contraindications to AIT and some ways to improve the safety of this method of treatment of allergic diseases.

 

Key words: allergen immunotherapy, adverse reactions, contraindications to allergen immunotherapy

Обсуждение закрыто.

Яндекс.Метрика